# Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI

> **NCT03081208** · PHASE3 · COMPLETED · sponsor: **ObsEva SA** · enrollment: 810 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Nolasiban 900mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03081208
- **Lead sponsor:** ObsEva SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-06
- **Primary completion:** 2018-03-21
- **Final completion:** 2019-02-19
- **Target enrollment:** 810 (ACTUAL)
- **Last updated:** 2019-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081208, "Phase 3 Placebo Controlled Study of Nolasiban to Improve Pregnancy Rates in Women Undergoing IVF/ICSI". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03081208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*